Variant report
Variant | nsv874067 |
---|---|
Chromosome Location | chr2:51563316-51606559 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NRXN1-2 | chr2:51571329-51571385 | XLOC_002094 |
2 | lnc-NRXN1-2 | chr2:51569718-51569850 | XLOC_002094 |
3 | lnc-NRXN1-2 | chr2:51569718-51569990 | XLOC_002094 |
4 | lnc-CHAC2-4 | chr2:51605233-51605311 | ENSG00000231918.1 |
5 | lnc-NRXN1-2 | chr2:51569718-51569990 | XLOC_002094 |
No data |
No data |
Variant related genes | Relation type |
---|---|
PDCD4 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17041596 | chr2:51563316-51563317 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540242464 | chr2:51563382-51563383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs62142927 | chr2:51569719-51569720 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs188971167 | chr2:51569722-51569723 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs62142928 | chr2:51569726-51569727 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs60326347 | chr2:51569749-51569750 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs142516067 | chr2:51569783-51569784 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs549327814 | chr2:51569899-51569900 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs567472971 | chr2:51569909-51569910 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs146034330 | chr2:51569914-51569915 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs139955503 | chr2:51569926-51569927 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs571179282 | chr2:51569949-51569950 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs538396277 | chr2:51569961-51569962 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs143463704 | chr2:51569980-51569981 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs530021118 | chr2:51569986-51569987 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs535900955 | chr2:51573485-51573486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541171779 | chr2:51573499-51573500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62142930 | chr2:51573521-51573522 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs55981151 | chr2:51573524-51573525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568272734 | chr2:51573531-51573532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551088821 | chr2:51573554-51573555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569408911 | chr2:51573563-51573564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550714680 | chr2:51573581-51573582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139256564 | chr2:51573611-51573612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185508844 | chr2:51573672-51573673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370855602 | chr2:51573705-51573706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529943857 | chr2:51573727-51573728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557828660 | chr2:51573788-51573789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115654619 | chr2:51575804-51575805 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113016439 | chr2:51575812-51575813 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201889355 | chr2:51575813-51575814 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199509105 | chr2:51575834-51575835 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531473032 | chr2:51575847-51575848 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566556473 | chr2:51575850-51575851 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549367364 | chr2:51575863-51575864 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368629129 | chr2:51575895-51575896 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564532619 | chr2:51575927-51575928 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528492484 | chr2:51575960-51575961 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62142935 | chr2:51575971-51575972 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs555788365 | chr2:51575977-51575978 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561710639 | chr2:51575997-51575998 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182131931 | chr2:51576007-51576008 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187148235 | chr2:51576019-51576020 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146415571 | chr2:51576070-51576071 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191749236 | chr2:51576078-51576079 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571069303 | chr2:51576135-51576136 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538501316 | chr2:51576146-51576147 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539644261 | chr2:51576173-51576174 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75623814 | chr2:51576195-51576196 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140942367 | chr2:51576244-51576245 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51561600-51563400 | Enhancers | Liver | Liver |
2 | chr2:51562800-51563400 | Enhancers | Fetal Intestine Large | intestine |
3 | chr2:51573400-51573800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:51573400-51573800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr2:51575800-51577800 | Active TSS | NH-A | brain |
6 | chr2:51576200-51577800 | Active TSS | HUVEC | blood vessel |
7 | chr2:51576400-51577000 | Active TSS | Osteobl | bone |
8 | chr2:51576400-51577200 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr2:51577800-51578000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr2:51577800-51578000 | Enhancers | NH-A | brain |
11 | chr2:51581200-51581400 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
12 | chr2:51581400-51581600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr2:51581400-51581600 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
14 | chr2:51585000-51585600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr2:51605000-51619200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |